Friday, 8 March 2019
Government Holkar Science College is organising the INTERNATIONAL CONFERENCE ON PHARMACEUTICAL SCIENCES AND MEDICINE, which will be held on 29th and 30th of March 2019. The target audience for this conference are scientists, researchers, students of pharmaceutical and medical institutes, commercial enterprise entrepreneurs, training institutes, scientific devices manufacturing agencies, pharmacy technicians and drug management agencies. It is a scientific platform to follow and build networks and form connections with fellow key call manufacturers from all-round the educational establishments, health care Institutes, Pharmaceutical, Biotech, CROs offer chain, provision practitioners creating the conference an ideal platform to share expertise, foster collaborations through the analysis talks & displays to place forward several thought agitating ways. it is a good stage to brainstorm, discover new ideas, look for new skills and a platform to point out your capabilities and discoveries to the planet. The conference focuses on current and research-oriented 0topics like Medication Therapy Management, Drug Design, Risk Management in Pharmacy, Biopharmaceutical and plenty of additional, which will surely make you amazed and spell bound and will make your experience learning and memorable one. Prospective authors are invited to submit papers of their original works. We hope all participants will have new strategies to approach their researches, contemplate the bigger picture, and establish collaborations. The participant also honing their communication skills, discussing ideas, and getting input about their works.
Thursday, 7 March 2019
Associate Consultant, Health Economics Modelling
• The Health Economics Modelling Unit (HEMU) is a Business Unit within PAREXEL Access Consulting. HEMU is a dedicated unit with 30 staff based in the UK, US and Sweden, whose purpose is to provide health economics consultancy services to international pharmaceutical and medical devices companies.
• The unit focuses on the development of Health Technology Assessment compliant cost-effectiveness and budget impact analyses of drugs and devices. It will also include wider forms of modelling such as early economic models, payer value tools, and country adaptations.
• Projects may variously employ mathematical, statistical, economic and operational research modelling techniques applied to the evaluation of drugs and devices in a wide range of health conditions. The unit works closely with the other parts of PAREXEL Access Consulting including Evidence Review, and Pricing & Market Access which focus on systematic literature reviews, value communications, and HTA dossier development.